Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.
性状
Solid
IC50 & Target[1][2]
Cereblon
体外研究(In Vitro)
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride is composed of Degron (E3 ubiquitin ligase) and a linker, and they are used in PROTAC technology. Thalidomide-O-amido-PEG3-C2-NH2 binds to the targeting ligand to induce the target protein (including BRD4, BRD2, and BRD3) degradation. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献
[1]. Methods to induce targeted protein degradation through bifunctional molecules. WO2017007612A1.
溶解度数据
In Vitro: DMSO : 125 mg/mL (230.22 mM; Need ultrasonic)H2O : 100 mg/mL (184.17 mM; Need ultrasonic)配制储备液